Nanobiotix S.A. (EPA:NANO)
France · Delayed Price · Currency is EUR 31.30
+0.02 (0.06%)
Sep 11, 2026, 5:35 PM CET
Nanobiotix Market Cap
Nanobiotix has a market cap or net worth of €1.59 billion as of September 11, 2026. Its market cap has increased by 301.78% in one year.
Market Cap
1.59B
Enterprise Value
1.63B
Revenue
32.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
€31.30
ChartMarket Cap Chart
Since October 29, 2012, Nanobiotix's market cap has increased from 66.13M to 1.59B, an increase of 2,305.10%. That is a compound annual growth rate of 25.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 1.59B | 68.58% |
| Dec 31, 2025 | 943.39M | 558.09% |
| Dec 31, 2024 | 143.35M | -54.17% |
| Dec 29, 2023 | 312.82M | 147.96% |
| Dec 30, 2022 | 126.16M | -50.42% |
| Dec 31, 2021 | 254.47M | -46.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 8.74B |
| Inventiva | 868.33M |
| MedinCell | 782.87M |
| Genfit | 685.33M |
| DBV Technologies | 669.95M |
| Valneva SE | 549.41M |
| Valerio Therapeutics Société anonyme | 352.61M |
| Transgene | 241.56M |